Hannes Schmid

624 total citations
14 papers, 473 citations indexed

About

Hannes Schmid is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Hannes Schmid has authored 14 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Oncology. Recurrent topics in Hannes Schmid's work include Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and Cancer-related gene regulation (4 papers). Hannes Schmid is often cited by papers focused on Immune Cell Function and Interaction (5 papers), CAR-T cell therapy research (4 papers) and Cancer-related gene regulation (4 papers). Hannes Schmid collaborates with scholars based in Germany, United States and Switzerland. Hannes Schmid's co-authors include Madhumita Chatterjee, Jing Lu, Meinrad Gawaz, H.M. Liebich, Costanza Di Stefano, Dominik Schneidawind, Hildegard Keppeler, Corina Schneidawind, Guowang Xu and Xianbo Lu and has published in prestigious journals such as Blood, Oncogene and Journal of Chromatography A.

In The Last Decade

Hannes Schmid

14 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hannes Schmid Germany	11	231	151	96	68	38	14	473
Zhifang Hao China	13	282 1.2×	162 1.1×	54 0.6×	30 0.4×	12 0.3×	18	529
Yanwen Zhou Japan	16	394 1.7×	119 0.8×	158 1.6×	61 0.9×	25 0.7×	34	618
Jin‐Qiu Chen United States	10	313 1.4×	131 0.9×	282 2.9×	43 0.6×	48 1.3×	17	602
Tom Just Denmark	10	261 1.1×	115 0.8×	73 0.8×	52 0.8×	13 0.3×	10	574
Sergey Pryshchep United States	13	167 0.7×	388 2.6×	96 1.0×	57 0.8×	34 0.9×	15	669
Shaobo Yang China	12	189 0.8×	169 1.1×	161 1.7×	62 0.9×	36 0.9×	36	574
Sabrina Haag Sweden	13	171 0.7×	297 2.0×	142 1.5×	19 0.3×	28 0.7×	20	580
Hong Jin China	16	336 1.5×	83 0.5×	53 0.6×	41 0.6×	13 0.3×	33	597
Lubna Abuqayyas United States	13	255 1.1×	141 0.9×	81 0.8×	61 0.9×	12 0.3×	19	522
Ewa Gruszewska Poland	13	167 0.7×	94 0.6×	46 0.5×	199 2.9×	54 1.4×	50	505

Countries citing papers authored by Hannes Schmid

Since Specialization

Citations

This map shows the geographic impact of Hannes Schmid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannes Schmid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannes Schmid more than expected).

Fields of papers citing papers by Hannes Schmid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannes Schmid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannes Schmid. The network helps show where Hannes Schmid may publish in the future.

Co-authorship network of co-authors of Hannes Schmid

This figure shows the co-authorship network connecting the top 25 collaborators of Hannes Schmid. A scholar is included among the top collaborators of Hannes Schmid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannes Schmid. Hannes Schmid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Schairer, Rebekka, Hildegard Keppeler, Hannes Schmid, et al.. (2024). PD-1 checkpoint inhibition enhances the antilymphoma activity of CD19-CAR-iNKT cells that retain their ability to prevent alloreactivity. Journal for ImmunoTherapy of Cancer. 12(1). e007829–e007829. 7 indexed citations

Schmid, Hannes, et al.. (2021). Phospho-Site Mutations in Transcription Factor Suppressor of Hairless Impact Notch Signaling Activity During Hematopoiesis in Drosophila. Frontiers in Cell and Developmental Biology. 9. 658820–658820. 10 indexed citations

Schmid, Hannes, Hildegard Keppeler, Klaus Schulze‐Osthoff, et al.. (2021). Human invariant natural killer T cells promote tolerance by preferential apoptosis induction of conventional dendritic cells. Haematologica. 107(2). 427–436. 14 indexed citations

Einhaus, Jakob, Ann‐Christin Pecher, Hannes Schmid, et al.. (2020). Inhibition of effector B cells by ibrutinib in systemic sclerosis. Arthritis Research & Therapy. 22(1). 66–66. 34 indexed citations

Keppeler, Hildegard, Hannes Schmid, Dominik Schneidawind, et al.. (2020). MAT2A as Key Regulator and Therapeutic Target in MLLr Leukemogenesis. Cancers. 12(5). 1342–1342. 21 indexed citations

Keppeler, Hildegard, Hannes Schmid, Dominik Schneidawind, et al.. (2019). Inhibition of DOT1L and PRMT5 promote synergistic anti-tumor activity in a human MLL leukemia model induced by CRISPR/Cas9. Oncogene. 38(46). 7181–7195. 26 indexed citations

Schmid, Hannes, Jakob Einhaus, Hildegard Keppeler, et al.. (2019). Invariant NKT Cells From Donor Lymphocyte Infusions (DLI-iNKTs) Promote ex vivo Lysis of Leukemic Blasts in a CD1d-Dependent Manner. Frontiers in Immunology. 10. 1542–1542. 12 indexed citations

Pecher, Ann‐Christin, Hannes Schmid, Hildegard Keppeler, et al.. (2019). Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Research & Therapy. 21(1). 9 indexed citations

Schmid, Hannes, Corina Schneidawind, Hildegard Keppeler, et al.. (2018). Culture-Expanded Human Invariant Natural Killer T Cells Suppress T-Cell Alloreactivity and Eradicate Leukemia. Frontiers in Immunology. 9. 1817–1817. 16 indexed citations

10.

Keppeler, Hildegard, Hannes Schmid, Dominik Schneidawind, et al.. (2018). Myc Drives MLL Leukemogenesis in a Human CRISPR/Cas9 Leukemia Model and Indirect Inhibition with JQ1 Diminishes Leukemia Activity. Blood. 132(Supplement 1). 2213–2213. 2 indexed citations

11.

Nagel, Anja C., Adriana Schulz, Markus Meier, et al.. (2017). Hairless-binding deficient Suppressor of Hairless alleles reveal Su(H) protein levels are dependent on complex formation with Hairless. PLoS Genetics. 13(5). e1006774–e1006774. 20 indexed citations

12.

Lu, Jing, et al.. (2016). CXCL14 as an emerging immune and inflammatory modulator. Journal of Inflammation. 13(1). 1–1. 171 indexed citations

13.

Xu, Guowang, Hannes Schmid, Xianbo Lu, H.M. Liebich, & Pin Lü. (2000). Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method. Biomedical Chromatography. 14(7). 459–463. 48 indexed citations

14.

Liebich, H.M., et al.. (1997). Quantitation of urinary nucleosides by high-performance liquid chromatography. Journal of Chromatography A. 763(1-2). 193–197. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact